Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Izzy who wrote (3552)	1/7/1998 9:36:00 PM
From: Oliver & Co	Respond to of 6136

"New Evidence Suggests Eradication of HIV Is Feasible" Reuters Health Information Services (01/06/98) ÿÿÿÿ New research published in the January issue of the Journal of Virology suggests that the HIV-1 reservoir in AIDS patients may be limited. Dr. Hanneke Schuitemaker of the Netherlands Red Cross and colleagues assessed HIV-1 variants in periphery, lymphoid, and nonlymphoid tissues and isolated syncytium-inducing and non-syncytium-inducing genotypes from various sites, including the brain, lung, and testes. The researchers said that, excluding brain tissue, they detected no signs of the existence of true tissue reservoirs for HIV-1. The presence of a distinct virus reservoir in the brain, they said, highlights the need to use drugs with good bioavailability in brain tissue as part of combination therapies.